期刊文献+

早卵泡期长效长方案最佳获卵数的探讨 被引量:2

Investigate the optimal number of oocytes retrieved of early follicular phase prolonged protocol
原文传递
导出
摘要 目的探讨早卵泡期长效长方案的最佳获卵数及在达到较高累积活产率(cumulative live birth rate,CLBR)的同时,减少卵巢过度刺激综合征(ovarian hyperstimulation syndrome,OHSS)的风险。方法回顾性队列研究分析2014年1月至2017年12月期间在郑州大学第三附属医院生殖医学科首次行体外受精或卵胞质内单精子注射助孕且采用早卵泡期长效长方案的患者作为研究对象。根据获卵数进行分组,A组:获卵数1~5枚;B组:获卵数6~10枚;C组:获卵数11~15枚;D组:获卵数16~20枚;E组:获卵数>20枚,分析5组患者的基础资料及临床数据。主要观察指标为CLBR和OHSS发生率。采用二元逻辑回归校正混杂因素,分析影响CLBR和OHSS发生率的因素。结果女方年龄的增加(aOR=0.93,95%CI=0.90~0.97,P<0.001)和体质量指数的增加(aOR=0.95,95%CI=0.92~0.99,P=0.02)是CLBR的危险因素,获卵数的增加(aOR=1.27,95%CI=1.20~1.35,P<0.001)是CLBR的保护因素。女方年龄越小(aOR=0.94,95%CI=0.91~0.97,P<0.001)、体质量指数减低(aOR=0.96,95%CI=0.93~0.99,P=0.04)、获卵数增加(aOR=1.84,95%CI=1.64~2.06,P<0.001)是OHSS发生率的危险因素。随着获卵数的增加(A组到C组),CLBR增长显著,差异有统计学意义[51.6%(157/304)、64.8%(869/1314)、75.2%(1334/1774),P<0.001],而C组、D组和E组间CLBR的差异无统计学意义(P>0.05)。随着获卵数增加(A组到E组),OHSS发生率增加显著,差异有统计学意义[0.3%(1/304)、3.3%(44/1314)、5.0%(88/1774)、9.8%(104/1065)、15.4%(77/499),P<0.001],尤其是在获卵数>15枚时,OHSS发生率明显增加。结论早卵泡期长效长方案中,获卵数在11~15枚,可获得较高的CLBR,且OHSS发生率较低,为适宜的获卵数区间。 Objective To investigate the optimal number of oocytes retrieved of early follicular phase prolonged protocol and to reduce the risk of ovarian hyperstimulation syndrome(OHSS)while achieving a high cumulative live birth rate(CLBR).Methods It was a retrospective cohort study.Patients who underwent the first in vitro fertilization or intracytoplasmic sperm injection in the Reproductive Center of the Third Affiliated Hospital of Zhengzhou University from January 2014 to December 2017 were included.According to the number of oocytes retrieved,we divided all patients into 5 groups,group A:1-5 oocytes,group B:6-10 oocytes,group C:11-15 oocytes,group D:15-20 oocytes,group E:>20 oocytes.The basic and clinical data of 5 groups were analyzed.The main outcome measures were CLBR and the incidence of OHSS.Binary logistic regression was used to correct confounding factors to analyze the factors affecting the CLBR and the incidence of OHSS.We calculated the CLBR and the incidence of OHSS in each group.Results The maternal age(aOR=0.93,95%CI=0.90-0.97,P<0.001)and body mass index(aOR=0.95,95%CI=0.92-0.99,P=0.02)were risk factors for CLBR.The number of oocytes retrieved was the protection factor for CLBR(aOR=1.27,95%CI=1.20-1.35,P<0.001).The maternal age(aOR=0.94,95%CI=0.91-0.97,P<0.001),body mass index(aOR=0.96,95%CI=0.93-0.99,P=0.04),and increase in the number of oocytes retrieved(aOR=1.84,95%CI=1.64-2.06,P<0.001)were the independent risk factors of the incidence of OHSS.With the increase of the number of oocytes retrieved(group A to group C),CLBR increased significantly[51.6%(157/304),64.8%(869/1314),75.2%(1334/1774),P<0.001],while the differences among groups C,D and E were not statistically significant(P>0.05).With the increase in the number of oocytes retrieved(group A to group E),the incidence of OHSS increased significantly[0.3%(1/304),3.3%(44/1314),5.0%(88/1774),9.8%(104/1065),15.4%(77/499),P<0.001],especially when the number of oocytes retrieved was>15.Conclusion For the early follicular phase prolonged protocol,the optimal number of oocytes retrieved is 11-15,which can obtain higher CLBR,and reduce the incidence of OHSS.
作者 张俊韦 刘曼曼 孙丽君 王兴玲 管一春 吴艳莉 杜明泽 Zhang Junwei;Liu Manman;Sun Lijun;Wang Xingling;Guan Yichun;Wu Yanli;Du Mingze(Reproductive Center of the Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中华生殖与避孕杂志》 CSCD 北大核心 2021年第4期307-312,共6页 Chinese Journal of Reproduction and Contraception
关键词 获卵数 累积活产率 卵巢过度刺激综合征 Number of oocytes retrieved Cumulative live birth rate Ovarian hyperstimulation syndrome
  • 相关文献

参考文献7

二级参考文献30

  • 1Tarlatzis B, Kolibianakis E. GnRH agonists vs antagonists. Best Pract Res Clin Obste Gynaecol, 2007, 21(1):57-65.
  • 2Luna M, Vela G, McDonald C, et al. Results with GnRH antagonist protocols are equivalent to GnRH agonist protocols in comparable patient populations. J Reprod Med, 2012, 57(3-4): 123.
  • 3Papanikolaou E, Pados G, Grimbizis G, et al. GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of hCG triggering? A randomized prospective study. Hum Reprod, 2012, 27(6): 1822-8.
  • 4Orvieto R, Meltzer S, Rabinson J, et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril, 2008, 90(4): 1294-6.
  • 5Al-Inany H, Abou-Setta A, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online, 2007, 14(5):640-9.
  • 6Huang SY, Huang HY, Yu HT, et al. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer. Taiwan J Obstet Gynecol, 2011, 50(4):432-5.
  • 7Borm G, Mannaerts B. Treatment with the gonadotrophin- releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod, 2000, 15(7): 1490-8.
  • 8Albano C, Felberbaum RE, Smitz J, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod, 2000, 15(3):526-31.
  • 9Cavagna M, Paes de Almeida Ferreira Braga D, Biaggioni Lopes F, et al. The effect of GnRH analogues for pituitary suppression on ovarian response in repeated ovarian stimulation cycles. Arch Med Sci, 2011, 7(3):470-5.
  • 10Al-Inany H, Abou-Setta A, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev, 2006:3.

共引文献112

同被引文献13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部